Nuvation Bio Inc. - 10-Q Filing

Nuvation Bio Inc. reports Q3 financial results including revenue from research and development services and royalty arrangements.

SEC EDGAR ·

Tickers: $NUVB

Read the full article at SEC EDGAR

More Regulatory news